Literature DB >> 6453256

Regulation of the Balb/c-3T3 cell cycle-effects of growth factors.

C D Stiles, W J Pledger, R W Tucker, R G Martin, C D Scher.   

Abstract

The platelet-derived growth factor (PDGF), which is found in serum but not in plasma, has been purified to homogeneity; it stimulates replication at a concentration of 10(-10) M. Brief treatment with PDGF causes density-inhibited Balb/c-3T3 cells to become competent to synthesize DNA; pituitary fibroblast growth factor (FGF) or precipitates of calcium phosphate also induce competence. Continuous treatment with plasma allows competent, but not incompetent, cells to synthesize DNA. A critical component of plasma is somatomedin, a group of hormones with insulin-like activity; multiplication-stimulating activity (MSA) or insulin replace plasma somatomedin in promoting DNA synthesis. We have studied the molecular correlates of competence and the role of SV40 gene A products in regulating DNA synthesis. Treatment of quiescent cells with pure PDGF or FGF causes the preferential synthesis of five cytoplasmic proteins (approximate molecular weight 29,000, 35,000, 45,000, 60,000, and 72,000 detected by SDS-PAGE under reducing conditions). Two of these competence-associated proteins (29,000 and 35,000 daltons) are insulin, or epidermal growth factor (EGF). PDGF, FGF, or calcium phosphate induce an ultrastructure change within the centriole of 3T3 cells; this ultrastructural modification of the centriole is detectable by immunofluorescence within 2 h or PDGF treatment. Plasma, EGF, or MSA do not modify the centriole. SV40 induces replicative DNA synthesis in growth-arrested 3T3 cells but does not cause this alteration in centriole structure. Gene A variants of SV40, including a mutant with temperature-sensitive (ts) T-antigen (ts A209), a deletion in t-antigen (dl 884), and several ts A209 strains containing t-antigen deletions were used to induce DNA synthesis in Balb/c-3T3 cells. Like wild type SV40, all strains induced DNA synthesis equally well under permissive or nonpermissive conditions. Addition of PDGF or plasma had little effect on SV40-induced DNA synthesis. Thus, the viral function that induces replicative DNA synthesis in Balb/c-3T3 cells. Like wild type SV40, all strains induced DNA synthesis equally well under permissive or nonpermissive conditions. Addition of PDGF or plasma had little effect on SV40-induced DNA synthesis. Thus, the viral function that induces replicative DNA synthesis in Balb/c-3T3 cells is not t and is not temperature sensitive. This SV40 gene function overrides the cellular requirement for hormonal growth factors. It does not induce transient centriole deciliation, a hormonally regulated event.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6453256     DOI: 10.1002/jss.400130408

Source DB:  PubMed          Journal:  J Supramol Struct        ISSN: 0091-7419


  9 in total

1.  Dynamics of Vascular Remodeling: An Overview and Bibliography.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

2.  Schwann cell proliferative responses to cAMP and Nf1 are mediated by cyclin D1.

Authors:  H A Kim; N Ratner; T M Roberts; C D Stiles
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

3.  Cytoplasmic transfer of the mitogenic response to platelet-derived growth factor.

Authors:  J C Smith; C D Stiles
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

4.  Enhanced synthesis and stabilization of Mr 68,000 protein in transformed BALB/c-3T3 cells: candidate for restriction point control of cell growth.

Authors:  R G Croy; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

5.  Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats.

Authors:  G R Grotendorst; G R Martin; D Pencev; J Sodek; A K Harvey
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

6.  Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis.

Authors:  E Hoberg; R Dietz; U Frees; H A Katus; B Rauch; A Schömig; G Schuler; F Schwarz; H Tillmanns; J Niebauer
Journal:  Br Heart J       Date:  1994-03

7.  The calcium signal for BALB/MK keratinocyte terminal differentiation counteracts epidermal growth factor (EGF) very early in the EGF-induced proliferative pathway.

Authors:  P P Di Fiore; J Falco; I Borrello; B Weissman; S A Aaronson
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

8.  Cell cycle-specific action of nerve growth factor in PC12 cells: differentiation without proliferation.

Authors:  B B Rudkin; P Lazarovici; B Z Levi; Y Abe; K Fujita; G Guroff
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598

9.  Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells.

Authors:  R A Majack; S C Cook; P Bornstein
Journal:  J Cell Biol       Date:  1985-09       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.